Relationship Between Helicobacter pylori Infection and Vitiligo: A Prospective Study

American Journal of Clinical Dermatology

Volumn 15, Issue 5, 2014, Pages 457-462

  Doğan, Zeynal ^a   Özdemir, Pınar ^a   Ekşioğlu, Meral ^a   Filik, Levent ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; UREA;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HOSPITAL DEPARTMENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SKIN DISEASE; TELOGEN EFFLUVIUM; TURKEY (REPUBLIC); UREA BREATH TEST; VITILIGO; VITILIGO DISEASE ACTIVITY SCORE; ALOPECIA; BLOOD; BREATH ANALYSIS; COMPLICATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; TURKEY; YOUNG ADULT;

ADULT; ALOPECIA; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BREATH TESTS; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TURKEY; UREA; VITILIGO; YOUNG ADULT;

EID: 84918815124     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.1007/s40257-014-0087-3     Document Type: Article

References (51)

1. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362:1597–604.
2. Konno M, Muraoka S, Takahashi M, Imai T. Iron-deficiency anemia associated with Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr. 2000;31:52–6.
3. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, Higuchi K, Arakawa T. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol. 2003;82:30–2.
4. Shin DW, Kwon HT, Kang JM, Park JH, Choi HC, Park MS, Park SM, Son KY, Cho BJ. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. Clin Gastroenterol. 2012;46:840–5.
5. Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B. Gastric Helicobacter pylori infection is associated with adverse metabolic traits in severely obese subjects. Obesity (Silver Spring). 2013;21:535–7.
6. Doğan Z, Filik L, Ergül B, Sarikaya M, Akbal E. Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study. Eur J Gastroenterol Hepatol. 2013;25:107–10.
7. Valsecchi R, Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol. 1998;78:440–2.
8. Qayoom S, Ahmad QM. Psoriasis and Helicobacter pylori. Indian J Dermatol Venereol Leprol. 2003;69:133–4.
9. Lankarani KB, Ravanbod MR, Aflaki E, Nazarinia MA, Rajaee A. High prevalence of Helicobacter pylori infection in Behcet’s disease. BMC Gastroenterol. 2014;31(14):58.
10. Novák J, Csiki Z, Sebesi J, Takáts A, Demeter P, Sipka S. Elevated level of Helicobacter pylori antibodies in Henoch-Schonlein purpura [in Hungarian]. Orv Hetil. 2003;144:263–7.
11. Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135:407–13.
12. Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, Kumagai Y, Fukunaga Y, Takahashi H. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun. 2006;74:248–56.
13. El Miedany YM, Baddour M, Ahmed I, Fahmy H. Sjogren’s syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine. 2005;72:135–41.
14. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124:91–6.
15. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med. 2004;140:766–7.
16. Röner S, Zinser E, Menges M, Wiethe C, Littmann L, Hänig J, et al. Minor role of bystander tolerance to fetal calf serum in a peptide-specific dendritic cell vaccine model against autoimmunity: comparison with serum-free cultures. J Immunother. 2008;31:656–64.
17. Shapira Y, Agmon-Levin N, Renaudineau Y, Porat-Katz BS, Barzilai O, Ram M, et al. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden. Exp Mol Pathol. 2012;93:386–90.
18. Tanaka A, Prindiville TP, Gish R, Solnick JV, Coppel RL, Keeffe EB, et al. Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol. 1999;31:664–71.
19. Vera JF, Gotteland M, Chavez E, Vial MT, Kakarieka E, Brunser O. Sucrose permeability in children with gastric damage and Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 1997;24:506–11.
20. Sagi L, Baum S, Agmon-Levin N, Sherer Y, Katz BS, Barzilai O, et al. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. Autoimmun Rev. 2011;10:527–53.
21. Ram M, Barzilai O, Shapira Y, Anaya JM, Tincani A, Stojanovich L, et al. Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med. 2013;51:1075–82.
22. Kivity S, Arango MT, Ehrenfeld M, Tehori O, Shoenfeld Y, Anaya JM, et al. Infection and autoimmunity in Sjogren’s syndrome: a clinical study and comprehensive review. J Autoimmun. 2014;14:53–5.
23. Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus. 2014;23:596–605.
24. Andreakos E. Targeting cytokines in autoimmunity: new approaches, new promise. Expert Opin Biol Ther. 2003;3:435–47.
25. Forabosco P, Gorman JD, Cleveland C, Kelly JA, Fisher SA, Ortmann WA, et al. Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun. 2006;7:609–14.
26. Roessner K, Wolfe J, Shi C, Sigal LH, Huber S, Budd RC. High expression of Fas ligand by synovial fluid-derived γδ T cells in Lyme arthritis. J Immunol. 2003;170:2702–10.
27. Sahashi K, Engel AG, Linstrom JM, Lambert EH, Lennon VA. Ultrastructural localization of immune complexes (IgG and C3) at the end plate in experimental autoimmune myasthenia gravis. J Neuropathol Exp Neurol. 1978;37:212–23.
28. Herzum M, Ruppert V, Küytz B, Jomaa H, Nakamura I, Maisch B. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol. 1994;26:907–13.
29. Ishida Y, Suzuki K, Taki K, Niwa T, Kurotsuchi S, Ando H, et al. Significant association between Helicobacter pylori infection and serum C-reactive protein. Int J Med Sci. 2008;5(4):224–9.
30. Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D’Elios MM, Amedei A, Azzurri A, et al. The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol. 2005;24:63–91.
31. Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmune Rev. 2014;13:549–62.
32. Onsun N, Arda Ulusal H, Su O, Beycan I, Biyik Ozkaya D, Senocak M. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. Eur J Dermatol. 2012;22:117–20.
33. Magen E, Mishal J. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria. Clin Exp Dermatol. 2013;38:7–12.
34. Bruscky DM, da Rocha LA, Costa AJ. Recurrence of chronic urticaria caused by reinfection by Helicobacter pylori. Rev Paul Pediatr. 2013;31:272–5.
35. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H pylori infection in patients with Behcet’s disease. World J Gastroenterol. 2007;13:2983–5.
36. Apan TZ, Gürsel R, Dolgun A. Increased seropositivity of Helicobacter pylori cytotoxin-associated gene-A in Behçet’s disease. Clin Rheumatol. 2007;26:885–9.
37. Avci O, Ellidokuz E, Simşek I, Büyükgebiz B, Güneş AT. Helicobacter pylori and Behçet’s disease. Dermatology. 1999;199:140–3.
38. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16:90–100.
39. Zhang BX, Lin M, Qi XY, Zhang RX, Wei ZD, Zhu J, et al. Characterization of circulating CD8 + T cells expressing skin homing and cytotoxic molecules in active non-segmental vitiligo. Eur J Dermatol. 2013;23:331–8.
40. Sravani PV, Babu NK, Gopal KV, Rao GR, Rao AR, Moorthy B. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol. 2009;75:268–71.
41. Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647–67.
42. Toussaint S, Kamino H, Elder D, Elenitas R, Jaworsky D, Johnson B. Noninfectous papular and squamous diseases. In: Elder D, Elenitsas R, Jaworsky C, Johnson Jr B, editors. Lever’s histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven; 1997:154–5.
43. Schallreuter KU, Wood JM, Pittelkow MR, Gütlich M, Lemke KR, Rödl W, et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science. 1994;263:1444–6.
44. Abdel Naser MB, Krüger-Krasagakes S, Krasagakis K, Gollnick H, Orfanos CE. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res. 1994;7:1–8.
45. Naughton GK, Eisinger M, Bystryn JC. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol. 1983;81:540–2.
46. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 1991;32:1473–7.
47. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol. 1994;47:61–6.
48. Fan XG, Chua A, Fan XJ, Keeling PW. Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. J Clin Pathol. 1995;48:133–6.
49. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor α, interleukin 1 beta, and interleukin 8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994;29:425–9.
50. Moss SF, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 1994;35:1567–70.
51. Warzecha Z, Dembiński A, Ceranowicz P, Dembiński M, Sendur R, Pawlik WW, et al. Deleterious effect of Helicobacter pylori infection on the course of acute pancreatitis in rats. Pancreatology. 2002;2(4):386–95.